Squamous cell carcinoma of the breast: Clinico-pathologic implications and outcome

K. A. Behranwala, N. Nasiri, Norlia Abdullah, P. A. Trott, Gerald P H Gui

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Aims: Pure squamous cell carcinoma (SCC) of the breast is a rare tumour and little is known about long-term outcome. We report our experience of a consecutive series of patients. Methods: All patients with SCC treated at our institution between 1970 and 2001 were included. The pathological features, outcome and prognosis were studied. Results: Eleven patients were identified. The median age was 55 (38-90) years and median follow-up was 62 (3-332) months. Four tumours were T1, three were T2 and three were T3 (one tumour size was unknown). There were seven poorly differentiated and three moderately differentiated SCC. Tumour grade could not be assessed in one patient. Primary treatment was mastectomy in six patients, wide local excision in four patients and radiotherapy in one patient. There was lymph node (LN) involvement in two patients. Oestrogen receptor status was assessed in seven patients and only one tumour was positive. Adjuvant chemotherapy was given to three patients and five patients received adjuvant radiotherapy. Two patients developed local recurrence at 5 and 12 months and three patients developed distant metastasis at 2, 36 and 306 months. Three patients were treated with chemotherapy at recurrence. Three patients have died of the disease, two are alive with disease and six remain well. The 2- and 5-year overall survival was 80% (SE = 13%) and 67% (SE = 16%) respectively. Large tumour size and positive LN status were prognostic indicators of poor outcome. Conclusion: SCC of the breast adopts an aggressive course with outcome comparable to poorly differentiated breast adenocarcinoma.

Original languageEnglish
Pages (from-to)386-389
Number of pages4
JournalEuropean Journal of Surgical Oncology
Volume29
Issue number4
DOIs
Publication statusPublished - May 2003
Externally publishedYes

Fingerprint

Squamous Cell Carcinoma
Breast
Neoplasms
Lymph Nodes
Recurrence
Adjuvant Radiotherapy
Mastectomy
Adjuvant Chemotherapy
Estrogen Receptors
Adenocarcinoma
Radiotherapy
Neoplasm Metastasis
Drug Therapy

Keywords

  • Breast cancer
  • Prognosis
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Squamous cell carcinoma of the breast : Clinico-pathologic implications and outcome. / Behranwala, K. A.; Nasiri, N.; Abdullah, Norlia; Trott, P. A.; Gui, Gerald P H.

In: European Journal of Surgical Oncology, Vol. 29, No. 4, 05.2003, p. 386-389.

Research output: Contribution to journalArticle

Behranwala, K. A. ; Nasiri, N. ; Abdullah, Norlia ; Trott, P. A. ; Gui, Gerald P H. / Squamous cell carcinoma of the breast : Clinico-pathologic implications and outcome. In: European Journal of Surgical Oncology. 2003 ; Vol. 29, No. 4. pp. 386-389.
@article{4af3163bc96044d1a19a715c94aa0aab,
title = "Squamous cell carcinoma of the breast: Clinico-pathologic implications and outcome",
abstract = "Aims: Pure squamous cell carcinoma (SCC) of the breast is a rare tumour and little is known about long-term outcome. We report our experience of a consecutive series of patients. Methods: All patients with SCC treated at our institution between 1970 and 2001 were included. The pathological features, outcome and prognosis were studied. Results: Eleven patients were identified. The median age was 55 (38-90) years and median follow-up was 62 (3-332) months. Four tumours were T1, three were T2 and three were T3 (one tumour size was unknown). There were seven poorly differentiated and three moderately differentiated SCC. Tumour grade could not be assessed in one patient. Primary treatment was mastectomy in six patients, wide local excision in four patients and radiotherapy in one patient. There was lymph node (LN) involvement in two patients. Oestrogen receptor status was assessed in seven patients and only one tumour was positive. Adjuvant chemotherapy was given to three patients and five patients received adjuvant radiotherapy. Two patients developed local recurrence at 5 and 12 months and three patients developed distant metastasis at 2, 36 and 306 months. Three patients were treated with chemotherapy at recurrence. Three patients have died of the disease, two are alive with disease and six remain well. The 2- and 5-year overall survival was 80{\%} (SE = 13{\%}) and 67{\%} (SE = 16{\%}) respectively. Large tumour size and positive LN status were prognostic indicators of poor outcome. Conclusion: SCC of the breast adopts an aggressive course with outcome comparable to poorly differentiated breast adenocarcinoma.",
keywords = "Breast cancer, Prognosis, Squamous cell carcinoma",
author = "Behranwala, {K. A.} and N. Nasiri and Norlia Abdullah and Trott, {P. A.} and Gui, {Gerald P H}",
year = "2003",
month = "5",
doi = "10.1053/ejso.2002.1422",
language = "English",
volume = "29",
pages = "386--389",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Squamous cell carcinoma of the breast

T2 - Clinico-pathologic implications and outcome

AU - Behranwala, K. A.

AU - Nasiri, N.

AU - Abdullah, Norlia

AU - Trott, P. A.

AU - Gui, Gerald P H

PY - 2003/5

Y1 - 2003/5

N2 - Aims: Pure squamous cell carcinoma (SCC) of the breast is a rare tumour and little is known about long-term outcome. We report our experience of a consecutive series of patients. Methods: All patients with SCC treated at our institution between 1970 and 2001 were included. The pathological features, outcome and prognosis were studied. Results: Eleven patients were identified. The median age was 55 (38-90) years and median follow-up was 62 (3-332) months. Four tumours were T1, three were T2 and three were T3 (one tumour size was unknown). There were seven poorly differentiated and three moderately differentiated SCC. Tumour grade could not be assessed in one patient. Primary treatment was mastectomy in six patients, wide local excision in four patients and radiotherapy in one patient. There was lymph node (LN) involvement in two patients. Oestrogen receptor status was assessed in seven patients and only one tumour was positive. Adjuvant chemotherapy was given to three patients and five patients received adjuvant radiotherapy. Two patients developed local recurrence at 5 and 12 months and three patients developed distant metastasis at 2, 36 and 306 months. Three patients were treated with chemotherapy at recurrence. Three patients have died of the disease, two are alive with disease and six remain well. The 2- and 5-year overall survival was 80% (SE = 13%) and 67% (SE = 16%) respectively. Large tumour size and positive LN status were prognostic indicators of poor outcome. Conclusion: SCC of the breast adopts an aggressive course with outcome comparable to poorly differentiated breast adenocarcinoma.

AB - Aims: Pure squamous cell carcinoma (SCC) of the breast is a rare tumour and little is known about long-term outcome. We report our experience of a consecutive series of patients. Methods: All patients with SCC treated at our institution between 1970 and 2001 were included. The pathological features, outcome and prognosis were studied. Results: Eleven patients were identified. The median age was 55 (38-90) years and median follow-up was 62 (3-332) months. Four tumours were T1, three were T2 and three were T3 (one tumour size was unknown). There were seven poorly differentiated and three moderately differentiated SCC. Tumour grade could not be assessed in one patient. Primary treatment was mastectomy in six patients, wide local excision in four patients and radiotherapy in one patient. There was lymph node (LN) involvement in two patients. Oestrogen receptor status was assessed in seven patients and only one tumour was positive. Adjuvant chemotherapy was given to three patients and five patients received adjuvant radiotherapy. Two patients developed local recurrence at 5 and 12 months and three patients developed distant metastasis at 2, 36 and 306 months. Three patients were treated with chemotherapy at recurrence. Three patients have died of the disease, two are alive with disease and six remain well. The 2- and 5-year overall survival was 80% (SE = 13%) and 67% (SE = 16%) respectively. Large tumour size and positive LN status were prognostic indicators of poor outcome. Conclusion: SCC of the breast adopts an aggressive course with outcome comparable to poorly differentiated breast adenocarcinoma.

KW - Breast cancer

KW - Prognosis

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0037636597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037636597&partnerID=8YFLogxK

U2 - 10.1053/ejso.2002.1422

DO - 10.1053/ejso.2002.1422

M3 - Article

C2 - 12711295

AN - SCOPUS:0037636597

VL - 29

SP - 386

EP - 389

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 4

ER -